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A B S T R A C T   
Carbon-conserving pathways have the potential of increasing product yields in biotechnological processes. The 
aim of this project was to investigate the functionality of a novel carbon-conserving pathway that produces 3 mol 
of acetyl-CoA from fructose-6-phosphate without carbon loss in the yeast Saccharomyces cerevisiae. This cyclic 
pathway relies on a generalist phosphoketolase (Xfspk), which can convert xylulose-5-phosphate, fructose-6- 
phosphate and sedoheptulose-7-phosphate (S7P) to acetyl phosphate. This cycle is proposed to overcome bot-
tlenecks from the previously reported non-oxidative glycolysis (NOG) cycle. Here, in silico simulations showed 
accumulation of S7P in the NOG cycle, which was resolved by blocking the non-oxidative pentose phosphate 
pathway and introducing Xfspk and part of the riboneogenesis pathway. To implement this, a transketolase and 
transaldolase deficient S. cerevisiae was generated and a cyclic pathway, the Glycolysis AlTernative High Carbon 
Yield Cycle (GATHCYC), was enabled through xfspk expression and sedoheptulose bisphosphatase (SHB17) 
overexpression. Flux through the GATHCYC was demonstrated in vitro with a phosphoketolase assay on crude 
cell free extracts, and in vivo by constructing a strain that was dependent on a functional pathway to survive. 
Finally, we showed that introducing the GATHCYC as a carbon-conserving route for 3-hydroxypropionic acid (3- 
HP) production resulted in a 109% increase in 3-HP titers when the glucose was exhausted compared to the 
phosphoketolase route only.   
1. Introduction 
The native routes for carbon conversion in microorganisms have 
been optimized through evolution, but not always in a way that is 
optimal for bioproduction of valuable products. In metabolic engineer-
ing, the metabolic network of a cell is optimized to increase the fluxes 
towards the product of interest, with the goal of improving the Titer, 
Rate and Yield (TRY) metrices (Nielsen and Keasling, 2016). The yeast 
Saccharomyces cerevisiae is an attractive industrial production host due 
to the robustness of the organism, ease of genetic manipulation and a 
vast knowledgebase being available (Nielsen and Jewett, 2008). 
S. cerevisiae is a Crabtree positive yeast (De Deken, 1966), which means 
that it will exhibit fermentative growth when glucose is in excess, even 
in aerobic conditions, with ethanol as the main product. When the 
glucose is consumed (marking the end of the glucose phase), the diauxic 
shift occurs, where S. cerevisiae reprograms its metabolism from 
fermentative growth to respiratory growth on ethanol. The growth on 
the produced ethanol is usually referred to as the ethanol phase. 
A key precursor metabolite for numerous industrially relevant 
products is acetyl coenzyme A (acetyl-CoA), whose bioconversion into 
different products can be enhanced by increasing its supply (Nielsen, 
2014). When an efficient platform strain (Rodriguez et al., 2015) with 
high flux towards acetyl-CoA has been established, it can be used as a 
starting point for creating strains producing any product derived from 
acetyl-CoA. Most biosynthetic pathways are located in the cytosol, 
which means that the production of cytosolic acetyl-CoA needs to be 
increased as acetyl-CoA cannot be transported freely between the 
compartments in S. cerevisiae. The native route for cytosolic acetyl-CoA 
* Corresponding author. Department of Biology and Biological Engineering, Chalmers University of Technology, Kemivägen 10, SE412 96, Gothenburg, Sweden. 
E-mail address: siewers@chalmers.se (V. Siewers).  
Contents lists available at ScienceDirect 
Metabolic Engineering 
journal homepage: www.elsevier.com/locate/meteng 
https://doi.org/10.1016/j.ymben.2020.09.003 
Received 3 June 2020; Received in revised form 11 August 2020; Accepted 3 September 2020   
Metabolic Engineering 62 (2020) 150–160
151
production in S. cerevisiae is the pyruvate dehydrogenase (PDH) bypass, 
consisting of pyruvate decarboxylase, acetaldehyde dehydrogenase and 
acetyl-CoA synthetase. Successful strategies in improving the cytosolic 
acetyl-CoA supply have been achieved by optimizing this native cyto-
solic pathway (Chen et al., 2014), however, a drawback with this 
pathway is the net cost of 1 ATP per acetyl-CoA formed from ½ glucose. 
This cost of ATP can negatively impact the yields of cytosolic acetyl-CoA 
derived products from glucose. Therefore, several successful strategies 
using heterologous pathways to provide cytosolic acetyl-CoA have been 
implemented (van Rossum et al., 2016). A widely used strategy involves 
transporting mitochondrial acetyl-CoA to the cytosol with the 
citrate-oxaloacetate shuttle, involving mitochondrial citrate synthase, 
citrate-α-ketoglutarate antiporter (Yhm2) and ATP-citrate lyase (Yu 
et al., 2018; Zhu et al., 2020). Furthermore, acetate formation and ATP 
cost in the PDH bypass can be avoided by converting acetaldehyde 
directly to acetyl-CoA by acetylating acetaldehyde dehydrogenase 
(Kozak et al., 2014a). Successful attempts have also been made to ex-
press the PDH complex from Enterococcus faecalis in the yeast cytosol 
(Kozak et al., 2014b). The main downside of most of these strategies is 
the loss of carbon as CO2, which decreases the theoretical product yield 
and the profitability of the process. Obtaining high yields is important as 
substrate costs may cover up to 75% of the total process costs (Lynd 
et al., 1999). 
An interesting enzyme in this respect is phosphoketolase, which can 
irreversibly convert fructose-6-phosphate (F6P) or xylulose-5-phosphate 
(X5P) to acetyl-phosphate (AcP) and erythrose-4-phosphate (E4P) or 
glyceraldehyde-3-phosphate (GAP). Dual activity towards both F6P and 
X5P is found for the bifidobacterial enzyme, where it is part of the bifid 
shunt (Suzuki et al., 2010). Phosphoketolase can be coupled to the 
enzyme phosphotransacetylase (Pta), which catalyzes the reversible 
reaction between AcP and acetyl-CoA, forming an attractive route for 
increased acetyl-CoA supply without any carbon loss. The phosphoke-
tolase pathway has been successfully deployed in yeast for poly-
hydroxybutyrate (Kocharin et al., 2013), fatty acid ethyl ester (de Jong 
et al., 2014) and farnesene (Meadows et al., 2016) production. The best 
performing strain for farnesene utilized a combination of a 
carbon-wasting but ATP and reducing power producing pathway, and a 
phosphoketolase-based carbon-saving pathway that however did not 
produce ATP or reducing power. 
Phosphoketolase is the key enzyme in the fructose-6-phoshate shunt 
(Schramm and Racker, 1957), which through carbon rearrangement can 
convert 1 mol of F6P to 3 mol of AcP without any loss of carbon, thus 
with a high potential of increasing yields. This cycle, nowadays referred 
to as non-oxidative glycolysis (NOG), is shown in Fig. 1A and has been 
utilized in Escherichia coli to convert xylose (Bogorad et al., 2013) and 
glucose (Lin et al., 2018) at near theoretical yields to acetate. However, 
there might be a possible bottleneck in this configuration as NOG in-
volves several reactions requiring two substrates (transaldolase and 
transketolase). 
Two new variants of the NOG pathway (Fig. 1B–C) have been pro-
posed through mathematical modelling by Andersen et al. (2019). These 
are made possible through a novel phosphoketolase activity towards 
sedoheptulose-7-phosphate (S7P). The first variant (Fig. 1B) was 
recently demonstrated to have in vivo activity in E. coli by Krüsemann 
et al. (2018). The authors used the phosphoketolase from Bifidobacterium 
adolescentis, which was shown to act upon X5P, F6P and S7P (Xfspk), and 
named the cycle the phosphoketolase shunt. This cycle does not require 
the transketolase step. The second variant of the NOG pathway proposed 
by Andersen et al. (2019) is shown in Fig. 1C, here named the Glycolysis 
AlTernative High Carbon Yield Cycle (GATHCYC) and will be evaluated 
in this paper. This cycle uses Xfspk from Bifidobacterium longum, which 
also has been shown to have activity on S7P (Beck et al., 2015), and does 
not include a transketolase or transaldolase step. All genes required, 
except the phosphoketolase, are already present in the S. cerevisiae 
genome. The sedoheptulose-1,7-bisphosphate aldolase (Sba) reaction is 
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reaction by Shb17, and both reactions are part of the riboneogenesis 
pathway in S. cerevisiae (Clasquin et al., 2011). 
In this paper, we first show that the NOG configuration contains a 
kinetic bottleneck, which is resolved in the phosphoketolase shunt and 
the GATHCYC cycle. Secondly, we prove in vitro and in vivo activity of 
the GATHCYC pathway, using S. cerevisiae as the host. Finally, we show 
that this pathway increases the yield of the industrially relevant product 
3-hydroxypropionic acid (3-HP) during growth on glucose. 
2. Results 
2.1. COPASI model simulations 
Carbon-conserving pathways have the potential to increase product 
yields, but bottlenecks in the pathway could result in too low reaction 
rates and diminish, or even abolish, the benefit of a carbon-conserving 
pathway. In order to evaluate bottlenecks of the NOG pathway 
(Bogorad et al., 2013), a computational method based on the COPASI 
algorithm (Hoops et al., 2006) (http://copasi.org/) was employed using 
the reactions of the NOG pathway, including chemical species, enzyme 
concentrations and kinetic parameters of each reaction. The kinetic 
parameters were extracted from published data (Messiha et al., 2014; 
Smallbone et al., 2013; Teusink et al., 2000) and from data deposited on 
the Biomodels website (https://www.ebi.ac.uk/biomodels/ 
BIOMD0000000064). The enzyme concentrations were set not to limit 
the reaction flux when the substrates are available. 
The steady state simulation of NOG on fructose with a specific 
(Fig. S1) or generalist phosphoketolase (Fig. 2A) shows accumulation of 
intermediates, mostly S7P, that in vivo would normally block the use of 
the NOG pathway. A sensitivity analysis (Table S1) showed a strong 
correlation of S7P concentration and the equilibrium constants (Keq) of 
several enzymes: triose phosphate isomerase (Tpi), fructose 1,6-bisphos-
phate aldolase (Fba), ribulose-5-phosphate 3-epimerase (Rpe) and 
transketolase (Tkl). The equilibrium constants are parameters linked to 
the thermodynamics of the reaction and thus cannot be improved using 
enzyme engineering. Thus, these NOG configurations can be thermo-
dynamically and kinetically limited. The equilibrium constants, of Fba 
and Tpi in particular, indicate that the availability of glyceraldehyde 3- 
phosphate (GAP) will be limited. Thus, the pairing of GAP with S7P for 
the reaction Tkl: GAP + S7P → X5P + R5P or transaldolase (Tal): GAP +
S7P → F6P + E4P is limited. The depletion of GAP will create a bottle-
neck at the Tkl step and lead to S7P accumulation. 
To overcome this disadvantage, a new S7P activity (Spk) was pro-
posed to be introduced. In Fig. S2, different NOG configurations with 
Spk activities are presented. Interestingly, in the presence of all three 
Xpk, Fpk and Spk activities, there is no need of transketolase in the 
phosphoketolase shunt (Fig. 1B and Fig. S2D. Moreover, Andersen et al. 
(2019) also proposed the introduction of two new activities, Sba and 
Sbp, which forms the GATHCYC (Fig. 1C). This removes the need of Tal, 
which reduces the complexity of the pathway. The removal of Tal and 
Tkl is beneficial, as they catalyze reversible reactions, act on multiple 
substrates and require two substrates simultaneously for the reaction to 
occur. The kinetic steady-state simulations of the phosphoketolase shunt 
and the GATHCYC both reached a steady state with no intermediates 
accumulating (Fig. 2B–C), which indicates that the kinetic bottleneck of 
the NOG is resolved. The GATHCYC was chosen for further evaluation in 
vitro and in vivo, as the phosphoketolase shunt has already been evalu-
ated (Krüsemann et al., 2018) and because of the lower complexity of 
the GATHCYC. 
2.2. In vitro pathway evaluation 
The GATHCYC functionality in yeast was evaluated by deleting 
competing pathways and measuring in vitro formation of AcP from F6P. 
To enable the GATHCYC in S. cerevisiae, the transketolase (TKL1, TKL2) 
and the transaldolase genes (TAL1, NQM1) were deleted, in combination 
with overexpression of the native SBPase gene SHB17 (Clasquin et al., 
2011). Finally, PHO13 was deleted to avoid formation of sedoheptulose 
(Xu et al., 2016), and xfspk from B. longum was expressed from an 
episomal plasmid. A pathway-negative strain (JH10) was constructed as 
a control, which has the GATHCYC cycle disrupted through deletion of 
SHB17 (Fig. 3A). This strain will produce 3 times less AcP compared to 
the pathway-positive strain (JH9) if the pathway is functional. These 
two strains were evaluated in an in vitro phosphoketolase assay using 
crude cell free extracts (Bergman et al., 2016; Racker, 1962) (Fig. 3B), 
where the pathway-positive strain yielded a 2.7 times higher signal than 
Fig. 2. Kinetic time course simulations of different carbon-conserving path-
ways on fructose, using the LSODA solver. A) NOG configuration with a 
generalist phosphoketolase results in continuous increase of the S7P concen-
tration and does not reach steady state. B) The phosphoketolase shunt reaches a 
near steady state although with high plateau for R5P concentration. C) The 
GATHCYC configuration reaches steady state with low intermediate metabolite 
concentrations (<2 mM). 
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the control strain. The expected results align very well with the observed 
data, indicating that the pathway is functional. 
2.3. In vivo pathway evaluation 
In vivo activity was demonstrated by constructing a strain that was 
dependent on a functional GATHCYC cycle to survive, see Fig. 4A. 
Knockout of both transketolase genes and the glucose-6-phosphate de-
hydrogenase gene (ZWF1) has been reported to be lethal for S. cerevisiae, 
even when grown in rich media (Schaaff-Gerstenschläger et al., 1993). 
These deletions block the formation of R5P, needed for histidine and 
nucleotide biosynthesis (Deutscher et al., 2006; Krüsemann et al., 2018). 
Only strains with a functional GATHCYC cycle will be able to produce 
the R5P required for growth, similar to the experimental setup regarding 
the phosphoketolase shunt (Krüsemann et al., 2018). 
The GATHCYC strain was further engineered by integrating 2 copies 
of xfspk, 1 copy of pta from Clostridium kluyveri and by deletion of GPP1 
to reduce the promiscuous breakdown of AcP to acetate (Bergman et al., 
2016; Meadows et al., 2016). In this strain (JH25), ZWF1 was success-
fully deleted (JH40) and the GATHCYC was shown to support growth 
when grown in minimal media (Fig. 4B). ZWF1 deletion was not possible 
in the shb17Δ background (JH46). Therefore, ZWF1 was instead 
downregulated when grown on glucose by exchanging the ZWF1 pro-
moter with the GAL1 promoter (JH45) as a negative control. This creates 
a system where ZWF1 is expressed in galactose conditions, but only at 
very low levels when glucose is present (Weinhandl et al., 2014). JH45 
was constructed with galactose as a carbon source and ZWF1 down-
regulation was shown to reduce the growth rate in this background 
when grown in minimal media with glucose (strain JH45 and JH46, 
Fig. 4B). ZWF1 downregulation did not have a major effect in the 
GATHCYC background (strain JH44, Fig. 4B); however, its deletion 
resulted in a longer lag phase and lower growth rate, while still reaching 
the same biomass level (strain JH40, Fig. 4B). These results show that 
the cycle has sufficient activity in vivo to rescue the R5P deficiency in a 
tkl1Δ tkl2Δ zwf1Δ background. The combined results from the in vitro 
and in vivo experiment show that the GATHCYC pathway is functional 
and can now be extended to produce a proof-of-concept product to test 
the strain for improved yields. 
2.4. 3-HP production in yeast 
3-Hydroxypropionic acid (3-HP) was chosen as a proof-of-concept 
product for evaluation of the GATHCYC cycle as improved acetyl-CoA 
supply has previously been shown to increase 3-HP titers (Chen et al., 
2014). 3-HP is produced from acetyl-CoA in two steps: conversion of 
acetyl-CoA to malonyl-CoA by acetyl-CoA carboxylase, which is further 
converted to 3-HP by a two-step NADPH dependent reduction by 
malonyl-CoA reductase (MCR). JH25 was further engineered by inte-
grating the gene encoding a deregulated acetyl-CoA carboxylase 
(ACC1**) (Shi et al., 2014) into the genome and expressing the MCR 
from Chloroflexus aurantiacus (mcrca) (Hügler et al., 2002) from a 
high-copy plasmid. The final strain (JH27) was evaluated in shake flasks 
containing minimal media over 5 days for 3-HP production, and 
compared to a control strain with the phosphoketolase pathway but 
lacking the GATHCYC cycle (JH34). The GATHCYC resulted in 31% 
higher 3-HP levels, with 375 mg/L and 286 mg/L for JH27 and JH34, 
respectively (Fig. 5A), and 62% higher when normalized to the biomass 
(Fig. 5B), showing a benefit of using the GATHCYC with the mcrca 
expressed from a high copy plasmid. 
3-HP production was also evaluated in a strain with more stable 
expression of mcrca resulting from genomic integration to avoid possible 
effects from potential differences in the plasmid copy number between 
the cycle and control strain. One copy of the bifunctional mcrca under the 
control of the enhanced TDH3 promoter (Blazeck et al., 2012) increased 
the maximal growth rate in the GATHCYC strain from 0.13 to 0.19 h-1 
and control strain from 0.2 to 0.23 h-1 compared to plasmid-based 
expression (Fig. S3). Furthermore, the GATHCYC increased the 3-HP 
titer by 63% when glucose was exhausted, with 89 mg/L and 54 mg/L 
for JH28 and JH37, respectively, showing a benefit of the GATHCYC 
during the glucose phase (Fig. S4). However, one copy of mcrca yielded 
lower 3-HP titers for both strains and no improvement in 3-HP titers for 
the GATHCYC strain when the produced ethanol is consumed at the end 
of the ethanol phase: 121 and 133 mg/L 3-HP for JH28 and JH37, 
respectively at 72 h. These observations were verified by separating the 
native bifunctional mcrca into two subdomains, provided by Li et al. 
(unpublished data), which increases the activity of the enzyme. The 
more efficient mcrca showed an even higher benefit from of the GATH-
CYC during the glucose phase, with a 109% increase in 3-HP titer when 
glucose was exhausted (Fig. 6A). The split mcrca resulted in overall 
higher 3-HP titers for both strains, but the GATHCYC showed no in-
crease in final titers compared to the control after 96 h of cultivation 
(Fig. 6B). 
3. Discussion 
In this study, we evaluated the GATHCYC (Fig. 1C), a novel carbon- 
conserving cycle, proposed by Andersen et al. (2019) as a variant of the 
NOG, for cytosolic acetyl-CoA supply in S. cerevisiae. Obtaining a plat-
form strain with higher yields for acetyl-CoA derived products is very 
attractive as it will reduce the amount of carbon wasted, which can make 
the process more profitable. Several cyclic pathways have been evalu-
ated for carbon conservation (François et al., 2020), including NOG 
(Bogorad et al., 2013; Lin et al., 2018), EP-bifido (Wang et al., 2019) and 
glycoptimus (Lachaux et al., 2019). In silico analysis showed that the 
GATHCYC cycle circumvents the kinetic bottleneck of the NOG (Fig. 2), 
which suggests that it is more efficient. However, further in vitro and in 
vivo experiments are required to prove that this bottleneck is resolved. 
The GATHCYC cycle was enabled by the trifunctionality of the 
Fig. 3. GATHCYC pathway evaluation through an in vitro phosphoketolase assay 
on crude cell free extracts. A) Both strains have the required GATHCYC back-
ground and express xfspk from a high copy plasmid. The pathway-negative strain 
(JH10) is shb17Δ and cannot utilize the full cycle (faded). The pathway-positive 
strain (JH9) will utilize the full GATHCYC cycle through SHB17 overexpression 
and is expected to produce 3 times more AcP than the pathway negative strain. 
B) Results of the phosphoketolase assay on crude cell free extracts. Strains were 
grown in biological triplicates and assayed in technical duplicates; error bars 
show the standard deviation. Asterisk (***) indicate a significant difference (p <
0.001, two-sided Student’s t-test with unequal variance).   
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phosphoketolase from B. longum, which after carbon rearrangement 
reactions can produce 3 mol of AcP from 1 mol of F6P. In vitro activity of 
the cycle was demonstrated by constructing a control strain with SHB17 
deletion to disrupt the cycle after the first phosphoketolase reaction, and 
the 3:1 ratio of formed AcP from F6P confirmed the functionality of the 
cycle (Fig. 3). 
E. coli also possesses all the enzymes necessary for the GATHCYC, 
except the phosphoketolase. The Sba reaction is performed by the native 
FbaA (Nakahigashi et al., 2009; Woolston et al., 2018) and SBPase ac-
tivity has been found for the native GlpX (Woolston et al., 2018). 
However, the major substrate for GlpX is FBP (Brown et al., 2009), while 
the S. cerevisiae Shb17 is more specific to SBP (Clasquin et al., 2011), 
making Shb17 a better choice for the GATHCYC. 
GATHCYC yeast strains without a phosphoketolase did not grow in 
minimal media. A high flux through the phosphoketolase is important to 
provide E4P to the shikimate pathway (Liu et al., 2019), as the aromatic 
amino acid (AAA) auxotrophy from the tkl1Δ tkl2Δ background 
(Schaaff-Gerstenschläger et al., 1993) is rescued by expression of xfspk 
from a 2μ plasmid or via genomic integration. Furthermore, genomic 
integration required 2 copies of xfspk to abolish the growth defect 
caused by lack of AAA, as addition of 1 more copy decreased lag time 
from 20 to 2.5 h, and increased maximal specific growth rate from 0.13 
to 0.19 h− 1 (strain JH18 and JH28, Figs. S3 and S5). This shows that 
Xfspk activity is limiting and coupled to growth, and could thus be 
improved by adaptive laboratory evolution. A previous study showed an 
80% increase in catalytic efficiency on F6P of the phosphoketolase from 
Bifidobacterium adolescentis when evolved in a host with defective 
phosphofructokinase (Dele-Osibanjo et al., 2019). 
We were able to show that the GATHCYC has sufficient activity in 
vivo to support growth in tkl1Δ tkl2Δ zwf1Δ, where all the R5P has to be 
produced from the GATHCYC (Fig. 4). In a strain with disrupted 
GATHCYC through deletion of SHB17, it was impossible to delete ZWF1 
as well, and it showed reduced growth when ZWF1 was downregulated 
with the GAL1 promoter on glucose (strain JH45 and JH46, Fig. 4B). 
Downregulation of ZWF1 in the cycle strain did not reduce strain per-
formance; however, its deletion resulted in slightly reduced growth 
(strain JH25, JH40 and JH44, Fig. 4B), indicating leakage of the GAL1 
promoter at glucose conditions. This could explain why ZWF1 down-
regulation still enables growth of the GATHCYC disrupted strain even 
though its deletion seemed to be lethal. 
The GATHCYC makes an effective route, in terms of carbon saving, 
towards acetyl-CoA. In this study, we did however not restrict the car-
bon flux through the GATHCYC alone due to the observed growth defect 
of strains relying on NOG (Lin et al., 2018), which also showed no 
growth-coupled production of acetate and a lack of reducing power. The 
GATHCYC suffers the same drawbacks as NOG (François et al., 2020), 
which means that it is beneficial for producing acetate, as acetate pro-
duction generates 2 ATP/glucose and requires no redox factor, but not 
for products that are more reduced than acetate. This led us not to 
disrupt ZWF1, PFK1-2, TDH1-3 or PGK1 for 3-HP production. A prom-
ising configuration for obtaining a high yield of acetyl-CoA derived 
products is by combining a carbon-conserving pathway together with a 
route to acetyl-CoA that produces ATP (Dele-Osibanjo et al., 2019; 
Fig. 6. 3-HP production comparison between GATHCYC (JH29) and phos-
phoketolase only (JH36) precursor supply pathway, with the split mcrca 
expressed from the genome. A) 3-HP titers at glucose exhaustion and B) optical 
density (OD600) and extracellular 3-HP concentrations during 4 d of cultivation. 
Strains were grown in 50 mL minimal media containing 2% glucose and 100 
mg/L uracil, using biological triplicates; error bars show the standard deviation. 
Statistical analysis was performed with two-sided Student’s t-test with unequal 
variance (**p < 0.01). 
Fig. 5. 3-HP production comparison between GATHCYC (JH27) and phos-
phoketolase only (JH34) precursor supply pathway, with the mcrca expressed 
from a high copy plasmid. A) Optical density (OD600) and extracellular 3-HP 
concentration during 5 days of cultivation and B) 3-HP concentration normal-
ized to OD600 after 5 days of cultivation. Strains were grown in minimal media 
containing 2% glucose, using biological triplicates; error bars show the stan-
dard deviation. Statistical analysis was performed with two-sided Student’s t- 
test with unequal variance (**p < 0.01). 
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Meadows et al., 2016; van Rossum et al., 2016). This could for instance 
be achieved by using the GATHCYC and the acetylating acetaldehyde 
dehydrogenase pathway for acetyl-CoA supply, where most of the 
NADPH is generated from the oxidative pentose phosphate pathway. 
A combination of NOG and the native pathway in E. coli has been 
evaluated for acetone production, which improved yields from 0.38 to 
0.47 mol acetone/mol glucose (Yang et al., 2016). However, it was 
unclear if the yield improvement was caused by the phosphoketolase 
alone or from the NOG configuration. The phosphoketolase pathway 
should provide 1.5 mol of acetyl-CoA without carbon loss from glucose 
(Suzuki et al., 2010), whereas the NOG configuration should provide 3 
mol acetyl-CoA. In this study, we separated the yield increase of the 
GATHCYC from the phosphoketolase pathway alone by constructing a 
control strain (JH34) with the same background as the GATHCYC strain 
(JH27), except the modifications required for the GATHCYC (tkl1Δ, 
tkl2Δ, tal1Δ, nqm1Δ and SHB17 overexpression). The 31% increase in 
3-HP titers and 63% increase when normalized to biomass (Fig. 5) 
indicated that the cycle increased the acetyl-CoA supply during 
plasmid-based expression of mcrca. 
3-HP production from strains with genomic integration of the mcrca 
was also evaluated to rule out possible effects from differences in copy 
number of the high copy plasmid. Integration of one copy of mcrca 
improved growth rates and final OD600 for both strains compared to 
plasmid-based expression, but only improved the 3-HP titer during the 
glucose phase and mid ethanol phase (Figs. S3, S4 and S7). The low 3-HP 
levels from both strains suggested a possible bottleneck in the flux to 3- 
HP from malonyl-CoA, which could limit the benefit of increased pre-
cursor supply. Therefore, the more efficient split mcrca was utilized to 
achieve higher and stable 3-HP production. The split mcrca resulted in 
similar growth rates compared to native mcrca (Figs. S3 and S8), but 
more than double 3-HP titers compared to the control when glucose was 
consumed (Fig. 6A), verifying the increased precursor supply of acetyl- 
CoA by the cycle during the glucose phase. The precursor supply during 
the ethanol phase was not improved by the GATHCYC, with no final 
increase in 3-HP titers. This contradicts the plasmid-based results, but 
other factors, such as strain background, might have influenced the copy 
number of the plasmid with mcrca. This makes the results from the in-
tegrated mcrca more reliable. The GATHCYC relies on efficient flux 
through the phosphoketolase, and a previous study showed that the 
Xfpk/Pta route only improved precursor supply for free fatty acids 
during the glucose phase (Bergman et al., 2019b). 
The maximum acetate levels of the 3-HP producing strains ranged 
between 2 and 3 g/L (Figs. S6, S7 and S9). Accumulation of acetate is 
problematic as it acidifies the cytoplasm, and the cell is required to 
spend energy on pumping out acetate ions to maintain intracellular pH 
homeostasis (Ramos et al., 2016). Elevated amounts of acetate have 
been shown to be the result of phosphoketolase expression, where ace-
tate levels increased from 0.55 g/L to 1.1 g/L (Bergman et al., 2019a), 
which is usually resolved by GPP1 deletion (Bergman et al., 2016; 
Meadows et al., 2016). The high acetate levels in the strains in this study 
might be caused by a limitation in the flux from acetyl-CoA to 
malonyl-CoA, allowing AcP produced by the phosphoketolase to be 
hydrolyzed to acetate instead of being converted to acetyl-CoA by Pta. 
Another explanation could be an increased NADPH demand (Ferreira 
et al., 2004) during 3-HP production, as acetate production generates 
NADPH and high acetate levels have been observed in 3-HP producing 
strains before (Kildegaard et al., 2016). The high level of acetate for 
JH29 during the ethanol phase compared to JH36 could possibly explain 
the lower performance in 3-HP production of JH29 during the ethanol 
phase (Fig. 6B and Fig. S9). 
Glycerol is produced to oxidize excess NADH resulting from biomass 
formation during fermentative growth, which is important for main-
taining the redox balance (Dijken and Scheffers, 1986). The produced 
glycerol was readily consumed by the control strains, which was not the 
case for the GATHCYC strains (Figs. S6, S7 and S9). CEN. PK strains do 
not grow on glycerol as a sole carbon source (Swinnen et al., 2013), but 
should be able to metabolize glycerol when ethanol is present in the 
media (van Dijken et al., 2000). The inability of the GATHCYC strains to 
consume all the produced glycerol could be due to a redox imbalance, 
which could limit the performance of the GATHCYC strain. This redox 
imbalance is assumed to be indirectly caused by the disruption of the 
non-oxidative pentose phosphate pathway. Replacement of the 
non-oxidative pentose phosphate pathway with the GATHCYC pathway 
supports growth on the nonfermentable carbon sources ethanol and 
acetate but leaves 0.6–0.9 g/L glycerol in the media. Thorough char-
acterization of these strains in bioreactors is required to investigate this 
possible redox imbalance and uncover the reasons why glycerol is not 
fully consumed, with the end goal to further improve yields and strain 
performance. 
There are still optimizations needed to fully utilize the GATHCYC. 
Currently, GATHCYC strains have a longer glucose phase (Fig. S9), show 
a lower maximal growth rate (Figs. S3 and S8) and reach a lower final 
OD600 (Figs. 5 and 6 and S4) compared to the control strain with only the 
phosphoketolase pathway. Adding a second copy of the phosphoketo-
lase gene greatly improved strain performance (strain JH18 and JH28, 
Figs. S3 and S5), but still not to the level of the control. Phosphoketolase 
activity could still be limiting and balancing between the X5P, F6P and 
S7P activities might be necessary to increase strain performance further. 
Replacement of the non-oxidative pentose phosphate pathway with this 
artificial cycle could require additional strain engineering to reduce the 
growth defect appearing from this dramatic change in the central carbon 
metabolism. Extensive strain characterization will aid in uncovering the 
genomic modifications needed to improve strain performance of the 
GATHCYC strains. 
This study shows that the GATHCYC alone, without optimization of 
the native pathway to acetyl-CoA, results in a doubling of 3-HP titers at 
glucose exhaustion. Higher 3-HP titers could potentially be reached by 
increasing the copy number of the mcr gene, overexpression of PDH 
bypass genes, co-factor balancing and fed-batch fermentation as shown 
before (Kildegaard et al., 2016), combined with the GATHCYC as a 
carbon-conserving route to acetyl-CoA. van Rossum et al. (2016) 
showed that balancing the fluxes to acetyl-CoA between the 
carbon-conserving pathway NOG and pathways that generate co-factors 
and energy is expected to produce the highest yield of acetyl-CoA 
derived products. GATHCYC has the same acetyl-CoA yield and 
similar carbon rearrangement reactions as NOG and should therefore be 
compatible with this approach and be able to replace NOG as the 
carbon-conserving pathway. However, this needs to be experimentally 
verified. 
In conclusion, this study demonstrates a novel functional carbon- 
conserving cycle for acetyl-CoA supply in S. cerevisiae. The cycle was 
shown to be active in vitro, supporting growth in a zwf1Δ strain and 
increasing 3-HP titers by 109% after the glucose phase. With more 
optimization, the GATHCYC will be a value addition to a platform strain 
with increased yields of acetyl-CoA derived industrial products. 
4. Materials and methods 
4.1. COPASI model simulations 
Kinetic time course simulations of the carbon-conserving pathways 
were performed in COPASI, using the LSODA solver. Table S2 shows the 
kinetic parameters and initial concentrations of the species in the model. 
Different preferences of the phosphoketolase (XPK, FPK, SPK) were 
simulated by setting Vmax for each reaction to 0 mmol/(l*s) if no re-
action and to 0.6 mmol/(l*s) if the flux is needed. Fluxes were blocked 
when necessary by changing respective enzyme concentration from 1 to 
0 mmol/L. 
4.2. Cultivation media 
All chemicals were purchased from Sigma-Aldrich/Merck, unless 
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otherwise specified. The growth medium for yeast strain construction 
was yeast-peptone-dextrose (YPD), containing 10 g/L yeast extract, 20 
g/L peptone from meat and 20 g/L glucose. E. coli DH5α was used for 
plasmid construction and grown in lysogeny broth (LB), composed of 5 
g/L yeast extract, 10 g/L peptone from casein and 10 g/L NaCl. Agar- 
agar was added at 20 g/L and 16 g/L to make YPD and LB plates, 
respectively. 
E. coli transformants were selected on LB plates supplemented with 
100 μg/mL ampicillin. Selection of yeast transformants was performed 
on synthetic complete dropout (SD) plates without uracil, which con-
tained 6.9 g/L yeast nitrogen base (YNB) without amino acids (For-
medium), 0.77 g/L complete supplement mix (CSM) without uracil 
(Formedium), 20 g/L glucose and 20 g/L agar-agar. 5-Fluoroorotic acid 
(5-FOA) plates (containing 6.9 g/L YNB without amino acids, 0.77 g/L 
CSM without uracil, 50 mg/L uracil, 1 g/L 5-FOA (Formedium), 20 g/L 
glucose and 20 g/L agar-agar) was used to remove the URA3 marker. 
Cultivations prior phosphoketolase assay and 3-HP measurements 
were performed in minimal medium, which contained 7.5 g/L 
(NH4)2SO4, 14.4 g/L KH2PO4, 0.5 g/L MgSO4⋅7H2O, 20 g/L glucose, 1 
mL/L vitamin solution, 2 mL/L trace metal solution and pH set to 6.5 
with KOH. The vitamin solution and trace metal solution were prepared 
as previously described (Verduyn et al., 1992). Glucose was added at 
concentration of 20 g/L. Yeast was precultured in 14 mL cultivated tubes 
and main cultures consisted of 20 mL minimal medium in 100 mL 
unbaffled shake flasks incubated at 30 ◦C with 200 rpm orbital shaking. 
50 mL yeast cultures were cultivated in 250 mL unbaffled shake flasks. 
Cell density was measured through optical density at 600 nm (OD600). 
4.3. Yeast strain and plasmid construction 
The strains used in this study are shown in Table 1. S. cerevisiae 
IMX581, derived from S. cerevisiae CEN. PK113-5D (Entian and Kötter, 
2007), was used as the parental strain. Genomic modifications of 
S. cerevisiae IMX581 was performed by introducing a guide-RNA (gRNA) 
expressing plasmid according to workflow by Mans et al. (2015). 
E. coli transformations were performed according to Inoue et al. 
(1990). Table S3 shows all the plasmids used in this study. The plasmid 
pBS01A-xfspk contains the promiscuous phosphoketolase gene from 
Bifidobacterium longum NCC2705. 
All kits, enzymes and buffers were ordered from Thermo Fisher 
Scientific, unless otherwise specified. The gRNA sequences were 
designed with the online tool Benchling (https://benchling.com) and 
are listed in Table S4. PCR was performed with Phusion High-Fidelity 
DNA Polymerase and products purified using either the GeneJET Gel 
Extraction or PCR Purification Kit. Primers were ordered from Eurofins 
Genomics. 
Single and double genomic modifications were performed by cloning 
the gRNAs into pMEL10 and pROS10, respectively, using Gibson as-
sembly (NEB). The assembled plasmid was used to transform E. coli, 
extracted with the GeneJET Plasmid Miniprep Kit and verified by Sanger 
sequencing (Eurofins Genomics). Transformation of yeast was per-
formed with the lithium acetate/PEG method (Gietz, 2014). 
Repair fragments for gene deletions were ordered as two comple-
mentary 120 bp oligos (60 bp upstream and 60 bp downstream of the 
gene) and annealed before transformation. Sequences for repair frag-
ment oligos are found in Table S5. Fusion PCR (Zhou et al., 2012) was 
used to construct repair fragments for promoter replacement and the 
XII-1:PTEF1-xfspk cassette integration. The remaining genomic 
Table 1 
S. cerevisiae strains used in this study.  
Strain Genotype Notes Origin 
IMX581 MATa ura3-52 can1Δ::cas9-natNT2 TRP1 LEU2 HIS3 Cas9 expressing Mans et al. (2015) 
JH9 IMX581 tkl1/2Δ tal1Δ nqm1Δ pho13Δ PSHB17Δ::PTDH3 pBS01A-xfspk Pathway positive, phosphoketolase assay This study 
JH10 IMX581 tkl1/2Δ tal1Δ nqm1Δ pho13Δ shb17Δ pBS01A-xfspk Pathway negative, phosphoketolase assay This study 
JH18 IMX581 tkl1/2Δ tal1Δ nqm1Δ pho13Δ PSHB17Δ::PTDH3 XII-1::PTEF1-xfspk-TADH1 Pathway positive, 1 copy xfspk This study 
JH19 IMX581 tkl1/2Δ tal1Δ nqm1Δ pho13Δ shb17Δ 
XII-1::PTEF1-xfspk-TADH1 
Pathway negative, 1 copy xfspk This study 
JH25 IMX581 tkl1/2Δ tal1Δ nqm1Δ pho13Δ PSHB17Δ::PTDH3 XII-1::PTEF1-xfspk-TADH1 XI-1::PeTDH3-xfspk- 
TCYC1 
X-2::PeTEF1-pta-TCYC1 gpp1Δ 
Pathway positive This study 
JH27 IMX581 tkl1/2Δ tal1Δ nqm1Δ pho13Δ PSHB17Δ::PTDH3 XII-1::PTEF1-xfspk-TADH1 XI-1::PeTDH3-xfspk- 
TCYC1 
X-2::PeTEF1-pta-TCYC1 gpp1Δ X-4::PHXT7-ACC1**-TCYC1 pBS01A-mcr 
Pathway positive, 3-HP production This study 
JH28 IMX581 tkl1/2Δ tal1Δ nqm1Δ pho13Δ PSHB17Δ::PTDH3 XII-1::PTEF1-xfspk-TADH1 XI-1::PeTDH3-xfspk- 
TCYC1 
X-2::PeTEF1-pta-TCYC1 gpp1Δ X-4::PHXT7-ACC1**-TCYC1 XI-3::PeTDH3-mcr-TCYC1 
Pathway positive, 3-HP production This study 
JH29 IMX581 tkl1/2Δ tal1Δ nqm1Δ pho13Δ PSHB17Δ::PTDH3 XII-1::PTEF1-xfspk-TADH1 XI-1::PeTDH3-xfspk- 
TCYC1 
X-2::PeTEF1-pta-TCYC1 gpp1Δ X-4::PHXT7-ACC1**-TCYC1 XI-3::PHXT7-mcrC-TTEF2 + PTEF1-mcrN-TFBA1 
Pathway positive, 3-HP production, This study 
JH34 IMX581 XII-1::PTEF1-xfspk-TADH1 
XI-1::PeTDH3-xfspk-TCYC1 X-2::PeTEF1-pta-TCYC1 gpp1Δ X-4::PHXT7-ACC1**-TCYC1 pBS01A-mcr 
Control, 3-HP production This study 
JH36 IMX581 XII-1::PTEF1-xfspk-TADH1 
XI-1::PeTDH3-xfspk-TCYC1 X-2::PeTEF1-pta-TCYC1 gpp1Δ X-4::PHXT7-ACC1**-TCYC1 
XI-3::PHXT7-mcrC-TTEF2 + PTEF1-mcrN-TFBA1 
Control, 3-HP production This study 
JH37 IMX581 XII-1::PTEF1-xfspk-TADH1 
XI-1::PeTDH3-xfspk-TCYC1 X-2::PeTEF1-pta-TCYC1 gpp1Δ X-4::PHXT7-ACC1**-TCYC1 XI-3::PeTDH3-mcr-TCYC1 
Control, 3-HP production This study 
JH40 IMX581 tkl1/2Δ tal1Δ nqm1Δ pho13Δ PSHB17Δ::PTDH3 XII-1::PTEF1-xfspk-TADH1 XI-1::PeTDH3-xfspk- 
TCYC1 




JH44 IMX581 tkl1/2Δ tal1Δ nqm1Δ pho13Δ PSHB17Δ::PTDH3 XII-1::PTEF1-xfspk-TADH1 XI-1::PeTDH3-xfspk- 
TCYC1 
X-2::PeTEF1-pta-TCYC1 gpp1Δ PZWF1Δ::PGAL1 
Pathway positive, 
ZWF1 downregulated on glucose 
This study 
JH45 IMX581 tkl1/2Δ tal1Δ nqm1Δ pho13Δ 
XII-1::PTEF1-xfspk-TADH1 XI-1::PeTDH3-xfspk-TCYC1 
X-2::PeTEF1-pta-TCYC1 gpp1Δ shb17Δ PZWF1Δ::PGAL1 
Pathway negative, 
ZWF1 downregulated on glucose 
This study 
JH46 IMX581 tkl1/2Δ tal1Δ nqm1Δ pho13Δ 
XII-1::PTEF1-xfspk-TADH1 XI-1::PeTDH3-xfspk-TCYC1 
X-2::PeTEF1-pta-TCYC1 gpp1Δ shb17Δ 
Pathway negative This study  
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integrations were performed with the EasyClone-MarkerFree kit (Jes-
sop-Fabre et al., 2016). All primers used to generate the plasmid and 
repair constructs are found in Table S6. Transformants were verified 
through colony PCR and Sanger sequencing of the PCR product. Se-
quences of diagnostic primers are found in Table S7. The URA3 marker 
was recycled from successful transformants by plating on 5-FOA plates, 
and loss of plasmid confirmed by plating single colonies on both YPD 
and SD -ura plates. Clones that did not grow on SD -ura plates were 
cultivated in YPD overnight and cryopreserved at -80 ◦C in 15% sterile 
glycerol, using a CoolCell container to maintain viability during 
freezing. 
The gene coding for the phosphoketolase from Bifidobacterium lon-
gum NCC2705 (GenBank: AAN24771.1) was codon optimized for 
S. cerevisiae by Genscript (Table S8). The codon optimized xfspk was 
cloned into pBS01A (Hu et al., 2017) by restriction cloning with BcuI 
and NotI, placing it downstream of the TEF1 promoter. 
4.4. Yeast phosphoketolase assay 
The pathway was tested using purified crude cell free extracts. 
Briefly, single colonies of JH9 and JH10 were precultured for 3 d in 2 mL 
minimal media, using biological triplicates. The precultures were added 
to shake flasks containing 20 mL media at a starting OD600 of 0.1 and 
cultivated until an OD600 of 1. The cells were washed once with 10 mL 
MQ water and once with 10 mL protein extraction buffer (PEB), con-
taining 50 mM potassium phosphate buffer, 1 mM dithiothreitol, 2 mM 
MgSO4 and set to pH = 7.5. The cells were resuspended in 0.4 mL PEB 
and snap frozen in liquid N2 after removal of the supernatant. The cell 
pellet was stored at -80 ◦C until lysis. 
Cells were thawed on ice prior lysis, resuspended in 0.4 mL PEB and 
transferred to a 2 mL screw-cap tube containing 500 mg 425–600 μm 
glass beads (Sigma G-8772). Halt protease inhibitor cocktail (Thermo 
Fisher Scientific) was added to a final concentration of 1X. The cells 
were homogenized with a Precellys Evolution homogenizer, using 4 
cycles of 6800 rpm for 20 s, and kept on ice for 5 min between the cycles. 
The homogenate was transferred to an Eppendorf tube and cell debris 
spun down at 20 000 g for 10 min at 0 ◦C. The supernatant was trans-
ferred to a fresh tube and stored on ice. Harvesting and lysis procedures 
were performed on ice with cold solutions. The lysis and assay were 
performed on the same day. 
The protein concentration of the crude cell free extracts was deter-
mined in duplicates with a DC protein assay kit (Bio-Rad), using pre-
made BSA standards (Thermo Fisher Scientific). The samples were 
diluted to the same protein concentration with PEB. Production of acetyl 
phosphate was evaluated with the ferric acetyl hydroxamate method 
(Lipmann and Tuttle, 1945; Racker, 1962), according to a protocol 
modified from Bergman et al. (2016). Briefly, the assay was performed 
in a 96-well microplate, using a reaction volume of 75 μL consisting of 
50 mM potassium phosphate buffer (pH 7.5), 1 mM MgSO4, 8 mM 
iodoacetate, 23 mM NaF, 90 mM F6P and 130 μg crude cell free extract. 
Reactions with lithium acetyl phosphate standards (0–16 mM) were 
performed in the same reaction buffer, but without F6P and crude cell 
free extract. The reaction was started by the addition of the crude cell 
free extract, and the microplate was incubated at room temperature for 
2 h. The reaction was stopped, and the product converted to ferric acetyl 
hydroxamate, using the same procedure as described in Bergman et al. 
(2016), with the addition that the protein precipitate was removed by 
centrifuging the plate for 5 min at 2300 g. The supernatant was trans-
ferred to an empty plate and absorbance measured at 505 nm with the 
microplate reader FLUOstar® Omega (BMG Labtech GmbH). 
4.5. 3-HP production 
Single colonies of 3-HP producing strains were precultured in 2 mL 
minimal medium for 2 d. The precultures were used to inoculate 20 mL 
minimal medium at OD600 = 0.05 and cultivated for up to 5 d. Samples 
for high-performance liquid chromatography (HPLC) were centrifuged 
at 12.000 g for 10 min (+4 ◦C) and extracellular concentrations of 3-HP, 
glucose, ethanol, acetate and glycerol were determined as previously 
described (Chen et al., 2014). 
4.6. Growth profiler 
Microtiter plate growth was performed in Growth Profiler 960 
(Enzyscreen). Precultures were grown for 3 d in 2 mL minimal media 
supplemented with 100 mg/L uracil and used to inoculate 250 μL media 
at OD600 = 0.05 in biological and technical triplicates, using a 96-well 
plate (Enzyscreen CR1496d). JH45 was precultured in rich media with 
galactose as a carbon source (20 g/L), washed with MQ-water and 
minimal media and resuspended in minimal media before inoculation of 
the microplate. 
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